Table 4.
Amino acid variations of Pvs28 among worldwide isolates
| SS | EGF-1 | EGF-2 | EGF-3 | EGF-4 | RR | THR | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country | 0 0 5 |
0 1 4 |
0 5 2 |
0 5 3 |
0 6 5 |
0 7 9 |
0 8 1 |
0 8 7 |
0 9 5 |
0 9 8 |
1 0 5 |
1 0 6 |
1 1 0 |
1 1 3 |
1 1 6 |
1 4 0 |
1 5 9 |
1 7 9 |
1 9 1 |
2 0 8 * |
2 1 0 # |
2 1 4 $ |
GSGGE/D | 2 2 1 & |
2 2 2 @ |
Ref. |
| Sal-I | H | V | M | A | T | V | A | D | G | L | E | V | N | N | L | T | K | G | G | D | G | S | 6 | V | I | AAC99770 |
| Iran | • | • | L | • | T/K | • | • | • | • | • | • | • | • | • | • | S | • | • | • | • | • | • | 4-6 | • | • | [24] |
| Mexico | • | • | L | • | • | • | • | N | • | • | • | • | Y | • | • | S | • | • | • | • | • | • | 5-6 | • | • | [31] |
| Bangladesh | • | • | M/L | • | T/K | • | • | • | • | L/I | • | • | • | N/S | L/V | T/S | K/ R |
• | • | • | • | • | 5-7 | • | I/ M |
[25] |
| Thailand | • | • | M/L | A/V | T/K | • | A/V | • | G/N | L/I | E/K | V/E | • | • | L/V | T/S | • | • | • | • | • | • | 5-7 | • | • | [15] |
| India | • | • | L | • | K | • | • | • | • | • | • | • | • | • | • | S | • | • | • | • | • | • | 4 | • | • | [25] |
| India | H/T/Y | • | M/L | A/V | T/K | V/E | • | • | • | L/I | E/K | • | • | • | L/V | T/S | • | • | D | D/G | G/R | S/ T |
3-6 | V/L | I/M | [26] |
| S Korea | • | • | L | • | • | • | • | • | • | • | • | • | • | • | • | S | • | G/ E |
G/ R |
• | • | • | 6 | • | • | [22] |
| China (YN) | • | V/L | M/L | • | • | • | • | • | • | L/I | E/K | • | • | • | L/V | T/S | • | G/E | • | • | • | • | 5-6 | • | I/M | This study |
SS, secretary signal sequence; EGF, EGF-like domain; RR, repeat regions; THR, the C terminal hydrophobic region. Ref.: references. YN represented isolates from Yunnan Provinces in China. • indicates identical amino acid residues compared to the Salvador I strain.
*, #, $, &, @ represented amino acid residues 210, 212, 216, 223, 224 reported in reference 26, respectively.